Marine Microalgal Biorefinery for Bioactive Compound Production 2024
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Marine Biotechnology Related to Drug Discovery or Production".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 1314
Special Issue Editor
Special Issue Information
Dear Colleagues,
Given the sustainable status of marine microalgae as raw materials, their conversion into bioproducts is currently celebrated as a green solution with the potential to alleviate various challenges. In recent years, extensive research has been conducted on biotechnology and bioprocessing, aiming to enhance the technical and economic feasibility of producing bioproducts from various sources. Specifically, the development of synthetic biology and artificial intelligence has opened up opportunities for maximizing the potential productivity of marine microalgae. This special issue invites original research papers and reviews that focus on the latest innovative developments in marine microalgal bioprocess engineering, including upstream biotechnological advancements, downstream separation and purification processes, as well as discussions on the efficiency of the entire product and process lifecycle.
Dr. Xiaojin Song
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bioengineering technologies
- bioproducts
- cultivation
- fermentation
- high throughput screening
- marine microalgae
- metabolic engineering
- separation and purification processes
- synthetic biology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
